Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis

Mycobacterial Infections

Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort

J Infect Dis.

Katelaris AL, Jackson C, Southern J, Gupta RK, Drobniewski F, Lalvani A, Lipman M, Mangtani P, Abubakar I

doi: 10.1093/infdis/jiz430.

Viral Infections, Non-HIV

Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women

Vaccine.

Brady RC, Jackson LA, Frey SE, Shane AL, Walter EB, Swamy GK, Schlaudecker EP, Szefer E, Wolff M, McNeal MM, Bernstein DI, Steinhoff MC

doi: 10.1016/j.vaccine.

Further Publications AnesthesiologyFurther Publications PainFurther Publications Infectiology

Successes and failures of the live-attenuated influenza vaccine: can we do better?

Clin Infect Dis.

Matrajt L, Halloran ME, Antia R

doi: 10.1093/cid/ciz358.

Mycobacterial Infections

Trained innate immunity and resistance to Mycobacterium tuberculosis infection

Clin Microbiol Infect.

Koeken VA, Verrall AJ, Netea MG, Hill PC, van Crevel R

doi: 10.1016/j.cmi.2019.02.015.

Bacterial InfectionsHIV / AIDS

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials

Clin Infect Dis.

Campbell JR, Al-Jahdali H, Bah B, Belo M, Cook VJ, Long R, Schwartzman K, Trajman A, Menzies D

doi: 10.1093/cid/ciaa1169.

Viral Infections, Non-HIV

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Clin Infect Dis.

Staat MA, Payne DC, Halasa N, Weinberg GA, Donauer S, Wikswo M, McNeal M, Edwards KM, Szilagyi PG, Bernstein DI, Curns AT, Sulemana I, Esona MD, Bowen MD, Parashar UD, and the New Vaccine Surveillance Network (NVSN).

doi: 10.1093/cid/ciaa150.

Viral Infections, Non-HIV

Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx

Vaccine.

Hales C, Jochems SP, Robinson R, Solórzano C, Carniel B, Pojar S, Reiné J, German EL, Nikolaou E, Mitsi E, Hyder-Wright AD, Hill H, Adler H, Connor V, Zaidi S, Lowe C, Fan X, Wang D, Gordon SB, Rylance J, Ferreira DM

doi: 10.1016/j.vaccine.2020.01.070.

Viral Infections, Non-HIV

A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses

Vaccine.

van de Witte S, Nauta J, Montomoli E, Weckx J

doi: 10.1016/

Viral Infections, Non-HIV

Assessment of temporally-related acute respiratory illness following influenza vaccination

Vaccine.

Rikin S, Jia H, Vargas CY, Castellanos de Belliard Y, Reed C, LaRussa P, Larson EL, Saiman L, Stockwell MS

doi: 10.1016/j.vaccine.2018.02.105.

Related content

Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort

Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women

Successes and failures of the live-attenuated influenza vaccine: can we do better?

Trained innate immunity and resistance to Mycobacterium tuberculosis infection

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials

Continued Evidence of the Impact of Rotavirus Vaccine in Children Less than 3 Years of Age from the US New Vaccine Surveillance Network- a Multi-Site Active Surveillance Program, 2006-2016

Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx

A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses

Assessment of temporally-related acute respiratory illness following influenza vaccination